The amended Pharmaceutical Affairs Act embracing the Patent Linkage System, among others, devised to foster better development of the new biomedical industry in Taiwan through early resolution of patent disputes ...

At the beginning of January 2018, a patent linkage system, established in an attempt to resolve disputes on patent invalidity and infringement among brand drug companies and generic drug companies ...

At the beginning of January 2018, a patent linkage system was promulgated and introduced into the Pharmaceutical Affairs Act.

In order to more extensively protect pharmaceutical products and to encourage the development of pharmaceutical industry, the current legal system provides two specific patent related protections to pharmaceutical products ...